News
Researchers discovered a neuromelioidosis outbreak, caused by Burkholderia pseudomallei, after a clinic reused a saline solution opened with a periosteal elevator. Ten patients were infected ...
Studies were identified by a survey of PubMed, focusing on prospectively collected data for participants enrolled onto defined protocols for neoadjuvant treatment of osteosarcoma. In addition to ...
Spontaneously appearing animal cancers share features with human cancers, like osteosarcoma (bone cancer), prostate and breast cancers, non-Hodgkin lymphoma, and melanoma. New York-based ...
Alectinib in children and adolescents with solid or CNS tumors harboring ALK-fusions: A data update from the iMATRIX alectinib phase I/II open-label, multi-center study. This is an ASCO Meeting ...
OST-HER2 is an off-the-shelf immunotherapy candidate that has shown positive clinical data in both human pediatric and canine osteosarcoma. Parent company OS Therapies is advancing towards an FDA ...
Randle enjoyed Senior Night in February amid a battle with osteosarcoma, which is a type of bone cancer. He was diagnosed in December 2023 after the typically-fast runner and high-energy player ...
The market opportunity for OST-HER2 in treating canine osteosarcoma is estimated to exceed $150 million in the U.S. annually. This projection is supported by recent clinical data demonstrating the ...
Camryn Shull, a James Madison University graduate, died at 22 after battling osteosarcoma. The second annual Run for Cam 5K will be held in Staunton's Gypsy Hill Park on May 31 to honor Shull's memory ...
The Company is seeking to gain FDA approval for lead asset OST-HER2 in the treatment of pediatric recurrent, fully-resected, lung metastatic osteosarcoma by the end of 2025. Phase 3-stage OST-AXIL ...
Diagnosed with acute osteosarcoma cancer in November last year, Ms Hinks said she and her family’s lives have been turned upside down once more. Magnetic Island resident Melia Hinks is battling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results